Recent

% | $
Quotes you view appear here for quick access.

Xinyuan Real Estate Co., Ltd. Message Board

w.ed93 113 posts  |  Last Activity: Apr 28, 2014 6:59 AM Member since: Sep 9, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • for those of you who purchased puts & shorted, time to take profit and move to FLML who will get a vote from FDA today as well.. for those who lost on pozn, this maybe a chance to get your money back.. whatever you do, dont dwell on this over-hype stocks. and for God's sake small investors please learn how to buy puts to hedge against your losses,, do exactly what the big boys do..

  • Reply to

    my short @$9.55 is looking good now...

    by w.ed93 Apr 27, 2014 8:54 AM
    w.ed93 w.ed93 Apr 27, 2014 11:54 PM Flag

    no not balls, just logic..

    Sentiment: Strong Sell

  • Reply to

    I expect we can move it to $6.10

    by ding_king2000 Apr 27, 2014 11:43 AM
    w.ed93 w.ed93 Apr 27, 2014 12:25 PM Flag

    You are doing some serious dreaming, they did not get approval or the consent to continue.. this will result in an automatic 50% drop in the stock

    Sentiment: Strong Sell

  • should open around $5 or $6.. will 5 figures in 4 days with this short.... the key was reading this board.. too much hype, pump action going on.. thanks board... :)... I will sip on some wine until monday...

    Sentiment: Strong Sell

  • have you all forgotten about the Feuerestein-Dr. Ratain rule. if not please google it and you will see Adam's take on biotechs possibility of getting approved. One of the approval markers is the company being valued above 300 million several months before FDA meeting. Clearly POZN does not meet that marker. so i will stay out of this stock and recommend we all follow the Feuerstein-Ratain rule..

  • no use of crying over spilled milk,, take what you have left and play POZN, and for god-sake's, only buy stocks that you can use PUT options to hedge against loss.

    Sentiment: Strong Buy

  • I am hoping he will write an article tomorrow on POZN...

  • Reply to

    What does Adam Feuerstein say about POZN?

    by w.ed93 Apr 22, 2014 6:06 AM
    w.ed93 w.ed93 Apr 22, 2014 11:08 AM Flag

    Adams's record on biotechs approval/disapproval is undeniable.... I advise anyone to await his word before purchasing any bio-tech..

    Sentiment: Hold

  • sorry everyone but i do not make a trade without knowing what Mr. Feuerstein gives his opinion. . He is correct a great percentage of the time.. Like him or not he is accurate. I hope he gives his opinion soon; if any of you know of his link or opinion already, please let me know. thanks..

    Sentiment: Strong Sell

  • I have been on the sidelines about this stock, I do see some similarities below with the company that received German reimbursement. Please read and share with me what you think, again I am on the sidelines hoping SSH falls below $8.50 and then I will be a sure buyer:

    Sequana Medical’s alfapump® system receives reimbursement in Germany for breakthrough technology in ascites management

    NUB grants approval for fifteen leading hepatology centres in Germany.

    Zürich, SWITZERLAND – 1.March 2012

    Sequana Medical announced today that its alfapump system has received German Neue Untersuchungs und Behandlungsmethode (NUB) approval which allows participating hospitals to receive reimbursement for innovative new products. Sequana Medical’s alfapump system is a fully implantable pump system designed to remove excess abdominal fluid, known as ascites, that collects in patients suffering from liver cirrhosis.

    “This year only 16% of products submitted to the NUB received approval. Selection of the alfapump system emphasizes the unmet medical need that exists in the management of refractory ascites and validates the alfapump system as a breakthrough technology in ascites management” said Dr. Noel Johnson, President and CEO of Sequana Medical.

    The alfapump system consists of a subcutaneously implanted battery-powered pump connected to a catheter placed in the abdominal cavity which automatically and continually collects ascites as it forms and moves it into the bladder, where it is eliminated from the patient through normal urination. “This innovative development marks the beginning of a completely new treatment option for cirrhosis patients suffering with refractory ascites”, says Professor Frank Lammert, Director, Department of Internal Medicine II, Saarland University Hospital, Homburg. Refractory ascites affects over 100,000 patients in Europe and the US every year and the number of patients is growing at an annual rate of 10% due to the accelerating incidence of hepatitis and obesity-related liver disease.

    Ascites is a common complication among patients with late-stage liver disease and is the leading reason for hospitalization among patients with cirrhosis. Paracentesis, which involves inserting a large-bore needle into the abdomen to drain 5-10 liters of accumulated ascites, is the most common procedure for the treatment of ascites. However, paracentesis has to be repeated frequently, often every 7-10 days, as it doesn’t prevent the re-accumulation of ascites. This repeated procedure is burdensome both to the patient and healthcare service provider.

    “The economic benefits of the alfapump system are substantial”, says Dr. Johnson. “Use of the alfapump system will provide considerable savings to payers by significantly reducing the requirement for paracentesis and avoiding repeated hospitalization.” The NHS National Innovation Centre in the UK recently estimated that the alfapump system could save the NHS £50 million per year. “Furthermore, the availability of this breakthrough technology to German hospitals will help to significantly improve the Quality of Life of patients suffering from refractory ascites. The successful NUB application for the alfapump is a major milestone for Sequana Medical,” concludes Johnson.

    The alfapump system was granted CE Mark in July 2011 and is currently being introduced into leading hepatology centres across Europe by Sequana Medical.

  • everyone, the float is simply too big for me to invest in this stock,, over 500 million and this is not exxon mobile,, any other stocks out there worth taking a look at for the new year..

    Sentiment: Sell

  • Reply to

    sold AAL, bought xideq..next bankruptcy success story.

    by w.ed93 Dec 24, 2013 11:43 AM
    w.ed93 w.ed93 Dec 27, 2013 12:06 PM Flag

    research further, only went into bankruptcy due to an interest payment...all operations are still a go for XIDEQ, much better shape than american airlines was before it going into bankruptcy.. on March 21, XIDEQ will present it plan to get out of bankruptcy. i am all in!!

    Sentiment: Strong Buy

  • xideq is the next bankruptcy company to emerge with success. AAMRQ went from .20 cent to $12.. people told me i was crazy for buying bankrupt stock aamrq @ .40 cent, but it worked out for me.. :).. XIDEQ, thank me later..

    Sentiment: Strong Buy

  • do your own DD, but people told me i was crazy when i purchased aamrq @ .35 cent and that turned out well for me.. xideq really did not need to go in bankruptcy but they did.. thank me later.

    Sentiment: Buy

  • my spending influences my investments, i am a distributor for USANA, Herblife & NTRI, but my stocks have made more for me than being a distributor... FVRG provides more upside than all my current MLM holdings, you should consider..

    Sentiment: Strong Buy

  • i own the stock FVRG and I am a distributor, the product is great and I love them.. the stock and company has much greater upside than Herblife & Nu Skin,,,,, both of which I am a distributor for and own both stocks.. I love contributing to my own bottom line, many of you should consider the same...

    my investment habits influence my spending habits and it has worked well for me during this time. when i buy a pizza i always buy papa johns, why because i own stock in papa john.. I am using everything I learned at Nu Skin & Amway for the succes of FVRG..

    Sentiment: Strong Buy

  • Reply to

    FVRG, consider owning stock & becoming a distributor.

    by w.ed93 Dec 19, 2013 12:33 PM
    w.ed93 w.ed93 Dec 19, 2013 11:35 PM Flag

    Please share with me which stock has the greatest upside FVRG or HLF or USANA... I'd rather spend the next 3 years building up my upline for FVRG than HLF... in fact I am now advising all of my dowline & upline to consider both buying the stock of FVRG & becoming distributor for greater profitability. any thoughts.

  • Reply to

    FVRG, consider owning stock & becoming a distributor.

    by w.ed93 Dec 19, 2013 12:33 PM
    w.ed93 w.ed93 Dec 19, 2013 1:45 PM Flag

    MLM has been the way of the future for the past 30 years now,, i will apply all that i learn from Amway, USANA & Herblife to FVRG or forever green, their products are more natural..

    Sentiment: Strong Buy

  • Reply to

    FVRG, consider owning stock & becoming a distributor.

    by w.ed93 Dec 19, 2013 12:33 PM
    w.ed93 w.ed93 Dec 19, 2013 1:11 PM Flag

    you are missing my point, i only shop at the retail stores i own stock in,, i have been involved in MLM for the past 20 years of my life and it has given me the freedom i desire, but i only achieved that freedom by being a direct seller(distributor) and owning the stock, i did the same with Amway... I also own stock and a distributor for USANA (USNA), & herblife... MLM offer me the ability to contribute to the company's bottom line.. FVRG does that as well.. i love the new FDA approved patch they sell for energy, once you try it, you will be a believer..

    Sentiment: Strong Buy

  • i own the stock FVRG and I am a distributor, the product is great and I love them.. the stock and company has much greater upside than Herblife & NuCor, both of which I am a distributor for and own both stocks.. I love contributing to my own bottom line, many of you should consider the same...

    my investment habits always influence my spending habits and it has worked well for me during this time. when i buy a pizza i always buy papa johns, why because i own stock in papa john..

XIN
2.79+0.07(+2.57%)Aug 31 4:06 PMEDT